Replimune Group, Inc. (REPL)

8.105 +0.08 (+0.93%) USD  |  NASDAQ  |  Jan 12, 16:00
8.10 0.00 (0.00%) After-Hours: 20:00
More

Replimune Group EBITDA (Per Share Quarterly)

EBITDA (Per Share Quarterly) Chart

View EBITDA (Per Share Quarterly) for REPL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA (Per Share Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Definition

View EBITDA Definition
Start Trial

EBITDA is an abbreviation for earnings before interest, taxes, depreciation, and amortization.

Read full definition.

EBITDA (Per Share Quarterly) Range, Past 5 Years

View EBITDA (Per Share Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA (Per Share Quarterly) Benchmarks

View EBITDA (Per Share Quarterly) Benchmarks
Start Trial
Rapt Therapeutics, Inc. Upgrade
Olema Pharmaceuticals, Inc. Upgrade
CorMedix, Inc. Upgrade
Verastem, Inc. Upgrade
Anavex Life Sciences Corp. Upgrade